Researchers at UT Arlington have discovered a key enzyme, IDO1, that when blocked, helps immune cells regain their ability to properly process cholesterol—something that breaks down during ...

Tens of thousands of people with the most aggressive type of heart disease could die as a result of insufficient diagnostic tests, experts have warned.

Heart attack survival odds have dramatically improved over the past 5 decades, but more people are dying from chronic cardiac ...

InterShunt Technologies announced today that it began an early feasibility study of its device for reducing heart failure symptoms.

Patients were screened from both a single cardiologist practice and a specialty heart failure (HF) clinic and were included ... making both interventions viable and better than treatment as usual. Our ...

“Thankfully, we’ve made progress in better identifying patients and administering treatment quickly, so they’re living longer, but they then develop the secondary consequence of progressive heart ...

With the FDA recently rejecting a drug application that aims to help those living with Barth Syndrome, one Bay Area family is ...

Regardless of chronic obstructive pulmonary disease status, finerenone mitigates clinical events and symptoms in patients with HFmrEF or HFpEF.

U.S. heart disease mortality has dropped 66% since 1970, mainly due to fewer ischemic heart disease deaths. However, deaths ...

Research shows heart attack deaths have plummeted by nearly 90% since 1970, while deaths from heart failure and arrhythmias ...

Advances in heart failure treatment have reduced hospitalizations by up to 30% and extended lives by years. Learn about prevention strategies and research developments.

References: Narayanan K, Reinier K, Teodorescu C, et al. Left ventricular diameter and risk stratification for sudden cardiac death. J Am Heart Assoc. 2014;3(5 ...